Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 October 2022 | Story Tsholo Maleho
UFS librarian Nambitha Manqola
UFS librarian Nambitha Manqola received top honours at the 2022 Library and Information Association of South Africa conference, scooping the association’s Emerging Librarian Award.

The University of the Free State Library and Information Services (UFS LIS) continues to deliver world-class services, with its staff members receiving national accolades.

Highlighting the library’s positive contributions, Nambitha Manqola, Chief Officer in the UFS LIS on the Bloemfontein Campus, recently scooped the Library and Information Association of South Africa (LIASA) - Nevada LMS Emerging Librarian Award at the association’s national conference hosted in Gauteng from 4 to 7 October 2022.

 

A role model for the Library and Information Services community

This award is given to someone who demonstrates characteristics indicating that they are a role model for the library and information services community, someone whose contributions could have a long-term impact on the sector, and someone who will be an ambassador for LIASA, Nevada LMS, and librarianship in the coming years, including embracing the post-modern digital landscape.

This accolade recognises the achievements and accomplishments of emerging, inspiring, and exceptional public, academic, school, and special librarians who have earned their LIS qualification within the past five years.

Manqola is known throughout the UFS LIS and Free State library community as a well-rounded individual who is gifted and skilled in a variety of areas, particularly technology. She is based in the UFS LIS Digital Scholarship Centre and is responsible for research data management, and library systems.

Her contribution to the UFS library's growth and marketing, especially during the COVID-19 pandemic, has left a lasting impression, making her an ambassador for how library professionals should embrace change and technology.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept